-transparent.png){kind=logo}
A range of 2-(,5-dihydroimidazolyl)-benzene, -quinoline, and -quinoxaline derivatives and 2-morpholino-4-catechol have been characterized as agonists or partial agonists for human platelet aggregation; and for inhibition of adenylate cyclase by measurement of their effect on platelet [cyclic-3',5'-AMP]. Antagonist activity for these compounds versus adrenaline as agonist has also been assessed for these two responses. The compounds can be divided into 4 groups. Group I contains compounds that are agonists for both responses; group II, compounds that are agonists for inhibition of adenylate cyclase but antagonists for the aggregatory response; group III, compounds that are agonists for the aggregatory response but are antagonists for inhibition of adenylate cyclase by adrenaline; and group IV, compounds that are antagonists for both responses. In group I the EC50 values for induction of aggregation are not significantly different from the EC50 values for inhibition of adenylate cyclase except for 2-morpholino-4-catechol which is significantly more potent as an inhibitor of adenylate cyclase. In group IV a linear correlation is observed between the K1 values for the two responses for 8 compounds but 2 other compounds do not conform to this correlation. The data are not consistent with a model in which a single chi 2-adrenoceptor mediates both the aggregatory response and inhibition of adenylate cyclase and hence support a model in which unique chi 2-adrenoceptors mediate these two responses.
K A Clare, and
M C Scrutton, and
N T Thompson
October 1985,
European journal of pharmacology,
K A Clare, and
M C Scrutton, and
N T Thompson
April 1993,
Lancet (London, England),
K A Clare, and
M C Scrutton, and
N T Thompson
January 1979,
Thrombosis research,
K A Clare, and
M C Scrutton, and
N T Thompson
September 1982,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K A Clare, and
M C Scrutton, and
N T Thompson
December 1979,
British journal of clinical pharmacology,
K A Clare, and
M C Scrutton, and
N T Thompson
January 1987,
Psychopharmacology,
K A Clare, and
M C Scrutton, and
N T Thompson
December 1975,
Biochemical pharmacology,
K A Clare, and
M C Scrutton, and
N T Thompson
July 1983,
Biochemical pharmacology,
K A Clare, and
M C Scrutton, and
N T Thompson
November 1993,
Biochimica et biophysica acta,
K A Clare, and
M C Scrutton, and
N T Thompson
December 1982,
Biochemical Society transactions,
